PMV Pharmaceuticals Logo

Presentations

Presentation – AACR 2022
Small Molecule Reactivators of Y220C Mutant p53 Modulate Tumor Infiltrating Leukocytes and Synergize with Immune Checkpoint Inhibitors

 

  • PMV Pipeline
  • PC14586
  • Clinical Trials
  • Access to Investigational Product
  • Presentations
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
    • Clinical Trials
    • Access to Investigational Product
    • Presentations
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • ESG
    • Stock Information
      • Stock Quote & Chart
    • Shareholder Services
      • FAQ
      • Email Alerts
      • Investor Contact
  • Life at PMV
    • Job Opportunities
    • Living in Princeton, New Jersey
  • Contact
  • Home
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
    • Clinical Trials
    • Access to Investigational Product
    • Presentations
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • ESG
    • Stock Information
      • Stock Quote & Chart
    • Shareholder Services
      • FAQ
      • Email Alerts
      • Investor Contact
  • Life at PMV
    • Job Opportunities
    • Living in Princeton, New Jersey
  • Contact
  • Terms of Use
  • Privacy Policy

PMV Pharmaceuticals Logo

© 2023 PMV Pharmaceuticals, Inc. All rights reserved
  • Terms of Use
  • Privacy Policy
Website Design: Hane Chow, Inc.